Results 221 to 230 of about 165,831 (308)

Canadian Allergy, Asthma and Immunology Foundation

Allergy, Asthma & Clinical Immunology, 2005
doaj   +1 more source

Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report. [PDF]

J Clin Immunol
Arslan S, Sert A, Özçelik M, Barış S, Aydoğmuş Ç, Kaba Ö, Çil Yılmaz B, Erdil S, Yırgın K, Gökmirza P, Çatak MC.   +10 more
europepmc   +1 more source

Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA

American Journal of Hematology, EarlyView.
ABSTRACT Frameshift mutations in exon 12 of nucleophosmin 1 (NPM1mut) are among the most common mutations in acute myeloid leukemia (AML) and have historically been considered favorable‐risk in the absence of FLT3‐ITD. In the European LeukemiaNet (ELN) 2024 risk‐classification for patients treated with hypomethylating agents plus venetoclax (HMA + VEN),
Fieke W. Hoff, Joshua F. Zeidner, Geeta Torlapati, Deedra Nicolet, Krzysztof Mrózek, Ying Huang, Alexander Li, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Maria R. Baer, Vu H. Duong, William G. Blum, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Rebecca L. Olin, Catherine C. Smith, Gary J. Schiller, Emily K. Curran, Onyee Chan, Christine McMahon, Michael Hochman, Kieran Sahasrabudhe, Charles Foucar, Jesus Gonzalez‐Lugo, Brittany Knick Ragon, Shivani V. Handa, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, Ann‐Katrin Eisfeld, John C. Byrd, Yazan F. Madanat   +44 more
wiley   +1 more source

Corrigendum to "Exploring the mediating roles of parenting & relationship quality in the association between early socioeconomic disparities and healthcare utilization for childhood allergic conditions: Longitudinal evidence from linked LSAC-Medicare data" World Allergy Organ J 19 (2026) 101393. https://doi.org/10.1016/j.waojou.2026.101393. [PDF]

World Allergy Organ J
Abebe AM, Hoque Z, Khanam R.
europepmc   +1 more source

Quizartinib in Combination With FLAG‐IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG‐QUIDA): A PETHEMA Phase I‐II Trial

American Journal of Hematology, EarlyView.
ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal, Javier Zambrano Márquez, Rebeca Rodríguez‐Veiga, Eduardo Rodríguez‐Arbolí, Juan Manuel Bergua‐Burgués, Susana Vives, Montserrat Arnán, Pilar Martínez Sánchez, Pilar Herrera‐Puente, Josefina Serrano‐López, Vicente Rubio, Inmaculada Marchante‐Cepillo, Marta Cervera‐Calvo, Andrés Novo García, Rosa Fernández Martín, Cristina Gil Cortés, Carlos Rodríguez‐Medina, Victor Noriega‐Concepción, Ana Alfonso‐Piérola, Carmen Loredo, María Antuña‐Casal, Blanca Boluda, Isabel Cano‐Ferri, Evelyn Acuña‐Cruz, Laura Torres‐Miñana, Joaquín Sánchez‐García, Cristina Bilbao, Maria Teresa Gómez‐Casares, David Martínez Cuadrón, Pau Montesinos   +29 more
wiley   +1 more source

Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis.

JAMA Pediatr
Islam N, Chu AWL, Sheriff F, Foroutan F, Guyatt GH, Brignardello-Petersen R, Oykhman P, Iorio A, Izcovich A, Morrison KM, Roldan Benitez Y, Couban RJ, Borovsky D, Zhang Y, Ologundudu L, Pasumarthi K, Farooq SF, Tong K, Tang WC, Faisal H, Khalid MF, Asif MS, French S, Waserman S, Chinthrajah RS, Sampson HA, Mustafa SS, Lieberman JA, Järvinen KM, Bailey S, Bégin P, Sicherer SH, Gerdts J, Carver M, Mitchell L, Cleary K, Greenhawt MJ, Wang J, Anagnostou A, Shaker MS, Chandra-Puri A, Fulkerson PC, Wood RA, Chu DK.   +43 more
europepmc   +1 more source

Clearance of corticosteroids in pediatric patients with active eosinophilic esophagitis: Faster than expected. [PDF]

Pediatr Allergy Immunol
Barbosa PFA, Sapienza MT, Pastorino AC, Yang AC, Yonamine GH, de Barros Dorna M, Castro APBM.   +6 more
europepmc   +1 more source

Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy [PDF]

, 2009
Przybilla B, BILÒ MB, Ruëff F, Interest group on Hymenoptera venom allergy of the European Academy of Allergology and Clinical Immunology., Jutel M, Mosbech H, Müller U   +6 more
core  

Clinical Predictors of Response in Chronic Graft‐Versus‐Host Disease: Results From the “Predicting the Quality of Response to Specific Treatments (PQRST)” Trial

American Journal of Hematology, EarlyView.
ABSTRACT Despite significant progress in chronic GVHD therapies, challenges remain in understanding pleomorphic phenotypes and varying responses to treatment. The aim of this study was to identify predictors of treatment response. We conducted a prospective, observational cohort study of patients beginning first‐, second‐, or third‐line systemic ...
Betty K. Hamilton, Lynn Onstad, Paul A. Carpenter, Joseph Pidala, George Chen, Corey Cutler, Najla El Jurdi, Nosha Farhadfar, Mark Juckett, Carrie L. Kitko, Catherine J. Lee, Stephanie J. Lee   +11 more
wiley   +1 more source

Algorithms of Patient Selection for Allergen Immunotherapy. [PDF]

Allergy
Zieglmayer UP, Arasi S, Eiwegger T, Jakob T, Klimek L, Ollert M.   +5 more
europepmc   +1 more source